Pshycho-social impact of presymptomatic testing in Machado-Joseph disease;Impacto psicológico do teste pré-sintomático na doença de Machado-Joseph. Resultados preliminares

Arquivos de Medicina

Volumn 18, Issue 1-2, 2004, Pages

  Fleming, Manuela ^a,b   Lêdo, Susana ^a,c   Rocha, José Carlos ^a,c   Sequeiros, Jorge ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Inst de Biol Molecular e Celular ^*

Author keywords

Anxiety; Coping; Depression; Genetic counselling

Indexed keywords

ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; EMOTION; HUMAN; INTERPERSONAL COMMUNICATION; MACHADO JOSEPH DISEASE; MAJOR CLINICAL STUDY; PATHOLOGY; PREDICTION; PSYCHOLOGICAL ASPECT; SOCIAL PSYCHOLOGY;

EID: 19644395532     PISSN: 08713413     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Coutinho Paula. Doença de Machado-Joseph: tentativa de definição (Tese de Doutoramento). ICBAS, Universidade do Porto.1992.
2. Takiyama Y, Nishizawa M, Kawashima S, et al. The gene for Machado-Joseph disease is mapped to human chromosome 14q. Nat Genet 1993;4:300-4.
3. Kawagushi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene from Machado-Joseph disease at chromosome 14q32. 1. Nat Genet 1994;8:221-7.
4. Sequeiros Jorge. Aconselhamento genético e teste preditivo na DMJ. In Sequeiros J (Ed.). O teste preditivoda Doença de Machado-Joseph. UnIGENe, Porto.1996.
5. Sequeiros Jorge. Historia da Doença de Machado-Joseph. In Sequeiros J (Ed.). O Teste Preditivo da Doença de Machado-Joseph. UnIGENe, Porto.1996.
6. Fanos L, Johnson J. Barriers to carrier testing for adult CF sibs: the importance of not knowing. Am J Med Genet 1995;59:85-91.
7. Codori A, Slavney PR, Young C, Migíoretti D, Brandt J. Predictors of psychological adjustment to genetic testing for Huntington's Disease. Health Psychol 1997;16:36-50.
8. Denayer L, Welkenhuysen M, Evers-Kiebooms G, Cassiman JJ, Van den Berghe H. The CF carriers status is not associated with a diminished self-concept or increase anxiety: results of psychometric testing after 1 year. Clinical Genetics 1996;49:232-6.
9. Tibben A, Timman R, Bannink E, Duivenvoorden H. Three years follow-up after presymptomatic testing for Huntington's Disease in tested individuals and partners. Health Psychol 1997;16:20-35.
10. Marteau T, Axworthy D, Dundas R. Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. Health Psychol 1997;16:51-62.
11. Vaz Serra A. Inventário de Avaliação Clínica da Depressão. Clínica Psiquiátrica dos Hospitals da Universidade de Coimbra.1994.
12. Vaz Serra A, Ponciano E, Relvas J. Aferição da Escala de Autoavaliação de Ansiedade de Zung, numa amostra da população portuguese -II- Sua avaliação como instrumento de medida. Psiquiatria Clínica 1982;3:203-13.
13. Fleming M. Intervenção Psicológica na Crise-A experiência com a Paramiloidose. In Sequeiros J (Ed.). O teste preditivo da Doença de Machado-Joseph. UnIGENe, Porto;1996.
14. Foster C, Watson M. Response to N. Dinnie and L. McKee's article "Genetic testing for breast cancer: technical ethical and quality of life issues". Health Psychology Update 1998;33:42-3.
15. Decruyenaere M, Evers-Kiebooms, Denayer L, et al. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling. Eur J Hum Genet 2000;8:130-6.
16. Watson M, Foster C, Brooks L, Eeles R, Evans G, Eccles D, Asheley S, Steering Group of the Cancer Research Campaing UK national study investigating the psychosocial impact of BRCA1/2. (Abstract). Journal of Medical Genetics 2000:37 (suppl II):A11.
17. Foster C. Genetic testing for cancer predisposition. Health Psychology Update 2002;11:6-9.